NO974035D0 - En ny vestfaktor og en genetisk sekvens som koder for denne - Google Patents

En ny vestfaktor og en genetisk sekvens som koder for denne

Info

Publication number
NO974035D0
NO974035D0 NO974035A NO974035A NO974035D0 NO 974035 D0 NO974035 D0 NO 974035D0 NO 974035 A NO974035 A NO 974035A NO 974035 A NO974035 A NO 974035A NO 974035 D0 NO974035 D0 NO 974035D0
Authority
NO
Norway
Prior art keywords
sequence encoding
factor
genetic sequence
new west
west
Prior art date
Application number
NO974035A
Other languages
English (en)
Other versions
NO320839B1 (no
NO974035L (no
Inventor
Nicholas Kim Hayward
Gunther Weber
Sean Grimmond
Magnus Nordenskjold
Catharina Larsson
Original Assignee
Amrad Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN1457A external-priority patent/AUPN145795A0/en
Priority claimed from AUPN6647A external-priority patent/AUPN664795A0/en
Priority claimed from AUPN7274A external-priority patent/AUPN727495A0/en
Application filed by Amrad Operations Pty Ltd filed Critical Amrad Operations Pty Ltd
Publication of NO974035D0 publication Critical patent/NO974035D0/no
Publication of NO974035L publication Critical patent/NO974035L/no
Publication of NO320839B1 publication Critical patent/NO320839B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO19974035A 1995-03-02 1997-09-02 Isolert polypeptid, fremgangsmate for dets fremstilling, isolert nukleinsyremolekyl, isolert antistoff, antisensemolekyl, preparat, anvendelse av henholdsvis et polypeptid og et nukleinsyremolekyl, vertscelle samt vektor. NO320839B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN1457A AUPN145795A0 (en) 1995-03-02 1995-03-02 A novel growth factor and a genetic sequence encoding same
AUPN6647A AUPN664795A0 (en) 1995-11-20 1995-11-20 A novel growth factor and a genetic sequence encoding same
AUPN7274A AUPN727495A0 (en) 1995-12-22 1995-12-22 A novel growth factor and a genetic sequence encoding same-II
PCT/AU1996/000094 WO1996027007A1 (en) 1995-03-02 1996-02-22 A novel growth factor and a genetic sequence encoding same

Publications (3)

Publication Number Publication Date
NO974035D0 true NO974035D0 (no) 1997-09-02
NO974035L NO974035L (no) 1997-11-03
NO320839B1 NO320839B1 (no) 2006-01-30

Family

ID=27157841

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974035A NO320839B1 (no) 1995-03-02 1997-09-02 Isolert polypeptid, fremgangsmate for dets fremstilling, isolert nukleinsyremolekyl, isolert antistoff, antisensemolekyl, preparat, anvendelse av henholdsvis et polypeptid og et nukleinsyremolekyl, vertscelle samt vektor.

Country Status (16)

Country Link
US (1) US20070135344A1 (no)
EP (1) EP0815221B1 (no)
JP (2) JPH11500139A (no)
KR (1) KR100414615B1 (no)
CN (1) CN1194090C (no)
AT (1) ATE252600T1 (no)
BR (1) BR9607628A (no)
CA (1) CA2214439C (no)
DE (1) DE69630442T2 (no)
ES (1) ES2206558T3 (no)
FI (1) FI120153B (no)
HK (1) HK1002963A1 (no)
HU (1) HU223438B1 (no)
NO (1) NO320839B1 (no)
NZ (2) NZ301611A (no)
WO (1) WO1996027007A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
EP0873348A4 (en) * 1995-06-06 2000-11-08 Human Genome Sciences Inc GROWTH FACTOR 3 OF THE HUMAN VASCULAR ENDOTHELIUM
EP1382679A3 (en) 1995-09-08 2004-11-10 Genentech, Inc. Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists
EP1553182B1 (en) 1995-09-29 2010-03-03 Universita Degli Studi Di Siena Regulated genes and uses thereof
WO1997017442A1 (en) 1995-11-08 1997-05-15 Immunex Corporation Flk-1 binding protein
US6994989B1 (en) 1995-11-08 2006-02-07 Immunex Corp. FLK-1 binding proteins
DK0956339T3 (da) 1996-08-23 2006-01-30 Licentia Oy Rekombinant vaskulær endotelcellevækstfaktor D (VEGF-D)
AU7250298A (en) * 1997-04-25 1998-11-24 Collateral Therapeutics, Inc. Truncated vegf-related proteins
SG117417A1 (en) 1998-02-06 2005-12-29 Collateral Therpeutics Inc Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
US7105481B2 (en) 1998-11-10 2006-09-12 Ludwig Institute For Cancer Research Method for stimulating connective tissue growth or wound healing
DK1129110T3 (da) 1998-11-10 2010-04-06 Ludwig Inst Cancer Res Blodpladeafledt vækstfaktor D, DNA kodende derfor og anvendelser deraf
AU764039B2 (en) 1998-12-07 2003-08-07 Zymogenetics Inc. Growth factor homolog ZVEGF3
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
AUPQ568100A0 (en) * 2000-02-16 2000-03-09 Amrad Operations Pty. Limited A method for producing recombinant molecules
AU2884102A (en) 2000-12-07 2002-06-18 Sangamo Biosciences Inc Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7981863B2 (en) * 2001-09-19 2011-07-19 Neuronova Ab Treatment of Parkinson's disease with PDGF
EP1869075B1 (en) 2005-02-28 2012-04-11 Sangamo BioSciences, Inc. Anti-angiogenic methods and compositions
CN100448892C (zh) * 2006-08-02 2009-01-07 中国人民解放军军事医学科学院基础医学研究所 抗肿瘤血管内皮生长因子受体vegf－r2抗原及其编码基因与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5219739A (en) * 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5338671A (en) * 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
DE69434538T2 (de) * 1994-03-08 2006-08-10 Human Genome Sciences, Inc. Vaskulärer endothelialer Wachstumsfaktor 2
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
US5607918A (en) * 1995-03-01 1997-03-04 Ludwig Institute For Cancer Research Vascular endothelial growth factor-B and DNA coding therefor

Also Published As

Publication number Publication date
EP0815221A4 (en) 1998-12-09
CN1194090C (zh) 2005-03-23
NO320839B1 (no) 2006-01-30
ES2206558T3 (es) 2004-05-16
FI973571A0 (fi) 1997-09-01
FI973571A (fi) 1997-10-30
HUP9800377A1 (hu) 1998-06-29
DE69630442T2 (de) 2004-08-19
JP2001037493A (ja) 2001-02-13
NZ337634A (en) 2001-06-29
HUP9800377A3 (en) 2000-12-28
JPH11500139A (ja) 1999-01-06
JP3683778B2 (ja) 2005-08-17
KR19980702702A (ko) 1998-08-05
BR9607628A (pt) 1999-11-30
DE69630442D1 (de) 2003-11-27
FI120153B (fi) 2009-07-15
ATE252600T1 (de) 2003-11-15
WO1996027007A1 (en) 1996-09-06
HU223438B1 (hu) 2004-07-28
US20070135344A1 (en) 2007-06-14
EP0815221A1 (en) 1998-01-07
KR100414615B1 (ko) 2004-05-27
CA2214439C (en) 2002-12-17
CN1224464A (zh) 1999-07-28
HK1002963A1 (en) 1998-09-30
EP0815221B1 (en) 2003-10-22
NO974035L (no) 1997-11-03
CA2214439A1 (en) 1996-09-06
NZ301611A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
NO974035D0 (no) En ny vestfaktor og en genetisk sekvens som koder for denne
DK0939767T3 (da) Procin faktor VIII og hybrider deraf
FI961886A (fi) Ihmisen Kunitz-tyyppiset proteaasi-inhibiittorit
ATE310015T1 (de) Hohe expressionsrate des grün-fluoreszierenden proteins
MXPA04003333A (es) Remodelado y glicoconjugacion de peptidos.
ATE189475T1 (de) Wachstums-differenzierungsfaktor der tgf-b familie
DK1346034T3 (da) von Willebrand-faktor (vWF) spaltende protease-polypeptid, nukleinsyre kodende for polypeptidet og anvendelse af polypeptidet
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
ATE360701T1 (de) Putrescin-n-methyltransferasepromotor
ATE370159T1 (de) Streptavidin-bindungspeptid
DE69230535T2 (de) Polyphenol oxidase gene
DK0719328T3 (da) Genet GRB 3-3, varianter deraf og anvendelse deraf
DE69634077D1 (de) Haemophilus adhäsionsproteinen
DK0877758T3 (da) Oprenset SR-p70-protein
ATE385805T1 (de) Neue peptide
PE20399A1 (es) Muteina ob
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
ES2122912A1 (es) Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein
UA35624C2 (uk) МОЛЕКУЛА ДНК, ЩО КОДУЄ ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, ВЕКТОР, L-КЛІТИНА, ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, СПОСІБ ЙОГО ОТРИМАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, МОНОКЛОНАЛЬНЕ АНТИТІЛО
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi
FI94051B (fi) Pectinatus-bakteerin proteiinifragmentteja
BR9607577A (pt) Método para inibir catepsina k

Legal Events

Date Code Title Description
MK1K Patent expired